Literature DB >> 29109015

Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.

Emily He1, Jie-Bin Lew2, Sam Egger3, Emily Banks4, Robyn L Ward5, Valerie Beral6, Karen Canfell7.   

Abstract

The Australian Government's National Bowel Cancer Screening Program (NBCSP) was introduced in 2006 to provide free home-based immunochemical faecal occult blood test (iFOBT) to eligible Australians turning 55 and 65years in that year. With the gradual inclusion of additional age cohorts, the rollout of the NBCSP is being implemented in the context of a degree of opportunistic or de facto screening. This study investigated factors associated with self-reported ever-uptake of the NBCSP and of any CRC screening using follow-up questionnaire data from 105,897 Australians aged ≥45years enrolled in the 45 and Up Study in New South Wales, Australia. Of the 91,968 study participants with information on CRC screening behaviour, 70,444 (76.6%) reported ever-uptake of any CRC screening. 63,777 study participants were eligible for a NBCSP invitation, of these 33,148 (52.0%) reported ever-uptake of screening through the NBCSP. Current smoking (RR=0.86, 0.83-0.90), non-participation in breast cancer screening (female) or PSA testing (male) (RR=0.84, 0.81-0.86), poor self-reported health (RR=0.89, 0.86-0.91), lower levels of education (RR=0.91, 0.90-0.93), and not speaking English at home (RR=0.88, 0.85-0.91) were associated with reduced ever-uptake of screening within the NBCSP and of any CRC screening. Individuals with a family history of CRC were less likely to screen through the NBCSP (RR=0.71, 0.69-0.73), but more likely to participate in any CRC screening (RR=1.18, 1.17-1.19). Smokers, disadvantaged groups and those with non-English speaking backgrounds are less likely to have ever-participated in organised screening through the NBCSP or in any form of CRC screening, supporting efforts to improve participation in these groups.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; National Bowel Cancer Screening Program; Participation; Screening; Uptake; iFOBT

Mesh:

Year:  2017        PMID: 29109015     DOI: 10.1016/j.ypmed.2017.10.032

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

Review 1.  Disparities in Recommendations for Colorectal Cancer Screening Among Average-Risk Individuals: An Ecobiosocial Approach.

Authors:  Sharifah Saffinas Syed Soffian; Azmawati Mohammed Nawi; Rozita Hod; Mohd Rizal Abdul Manaf; Huan-Keat Chan; Muhammad Radzi Abu Hassan
Journal:  Risk Manag Healthc Policy       Date:  2022-05-13

2.  Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia.

Authors:  Eleonora Feletto; Jie-Bin Lew; Joachim Worthington; Emily He; Michael Caruana; Katherine Butler; Harriet Hui; Natalie Taylor; Emily Banks; Karen Barclay; Kate Broun; Alison Butt; Rob Carter; Jeff Cuff; Anita Dessaix; Hooi Ee; Jon Emery; Ian M Frayling; Paul Grogan; Carol Holden; Christopher Horn; Mark A Jenkins; James G Kench; Maarit A Laaksonen; Barbara Leggett; Gillian Mitchell; Susan Morris; Bonny Parkinson; D James St John; Linda Taoube; Katherine Tucker; Melanie A Wakefield; Robyn L Ward; Aung Ko Win; Daniel L Worthley; Bruce K Armstrong; Finlay A Macrae; Karen Canfell
Journal:  BMJ Open       Date:  2020-06-21       Impact factor: 2.692

3.  The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study.

Authors:  Claire M Vajdic; Robert J MacInnis; Karen Canfell; Peter Hull; Maria E Arriaga; Vasant Hirani; Robert G Cumming; Paul Mitchell; Julie E Byles; Graham G Giles; Emily Banks; Anne W Taylor; Jonathan E Shaw; Dianna J Magliano; Julie Marker; Barbara-Ann Adelstein; Tiffany K Gill; Maarit A Laaksonen
Journal:  JNCI Cancer Spectr       Date:  2018-08-28

4.  Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.

Authors:  Joachim Worthington; Jie-Bin Lew; Eleonora Feletto; Carol A Holden; Daniel L Worthley; Caroline Miller; Karen Canfell
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

5.  Factors Associated with Knowledge, Attitudes, and Practice towards Colorectal Cancer and Its Screening among People Aged 50-75 Years.

Authors:  Florence M F Wong
Journal:  Int J Environ Res Public Health       Date:  2021-04-13       Impact factor: 3.390

6.  Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening.

Authors:  Markus Dines Knudsen; Ane Sørlie Kvaerner; Edoardo Botteri; Øyvind Holme; Anette Hjartåker; Mingyang Song; Espen Thiis-Evensen; Kristin Ranheim Randel; Geir Hoff; Paula Berstad
Journal:  BMC Cancer       Date:  2022-02-15       Impact factor: 4.430

7.  Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing.

Authors:  Edoardo Botteri; Geir Hoff; Kristin R Randel; Øyvind Holme; Thomas de Lange; Tomm Bernklev; Eline Aas; Mona Berthelsen; Erik Natvig; Benedicte Kirkøen; Markus D Knudsen; Ane S Kvaerner; Anna L Schult; Giske Ursin; Anita Jørgensen; Paula Berstad
Journal:  Int J Cancer       Date:  2022-04-22       Impact factor: 7.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.